Background: post menopausal period is a critical period for each female. How to
Introduction
Menopause is a critical period of a woman's life. It (6) Oxytocin (OT) is a neuropeptide predominantly synthesized within the magnocellular neurones of the hypothalamus. Interestingly, it is also synthesized in some peripheral tissues, including the reproductive system, heart, and bone. OT and its receptors are positively regulated by estrogens, through estrogen receptor beta (7).
It was found that osteoblasts in bone marrow produce abundant OT, suggesting that locally released OT may be an autocrine regulator of bone formation and bone mass. OT produced from osteoblasts in response to estrogen acts upon the OT receptors to stimulate further OT release, which amplifies estrogen action (8).
So our hypothesis in this study is that oxytocin administration may improve OP with better results than alendronate (the drug of choice in treating OP).
Materials and Methods
The present study was conducted in the physiology department, faculty of Medicine, Sohag University. This study was carried out in accordance with the guidelines of the University
Animal Ethics and approved by Research Ethics
Committee considering care and use of laboratory animals. 40 adult female albino rats, about (200-250) gm weight were chosen for this study. All rats were kept under observation for two weeks prior to the experiments to permit the animals to adjust to the environments. The animals were housed in standard suitable cages (20 × 32 × 20 cm for every 4 rats) at room temperature with normal light and dark cycle. They were maintained on a standard diet of commercial rat chow and tap water. Animals were subjected either to bilateral ovariectomies (OVX) from the dorsal approach or to sham surgery (in which the ovaries were not exteriorized but replaced intact), under intraperotinial sodium thiopental (40 mg/kg) anesthesia. The OVX rats were subjected to total ovariectomy, as reported previously (6). In brief, two paravertebral skin incisions were made while rats were under general anesthesia. The uterine tubes were ligated, and the incisions were closed following the removal of the ovaries. For antibiotic therapy, Ceftriaxone at a dose of 50 mg/kg was injected immediately before and 24 and 48h after surgery. The sham operated control group have the same previous incision, but with no excision of the ovaries. 7 weeks later (bone loss period), 40 adult female rats were divided into four groups (n꞊ 10):
1. Group І, (control group) after sham surgery, rats were received no treatment.
2. Group II, after being ovariectomized, rats were received vehicle (Ve) 1mg/kg/day intraperitoneal injection for 7 weeks.
3. Group III, after being ovariectomized, rats were received alendronate 0.1mg/kg/day intraperitoneal injection for 7 weeks.
4. Group IV, after being ovariectomized, rats were injected daily with Oxytocin 0.1 mg/kg intraperitoneal injection for 7 weeks according to the manufacture structure.
Collection of samples
At the end of the experimental period all animals were anaesthetized with thiopental sodium (40 mg/kg) intraperitoneally. Blood were being collected, centrifuged, and serum was stored at -80 c until the determination of serum ALP and Oxytocin.
1-Biochemical Parameters

Determination of serum Oxytocin:
Serum concentration of OT (OT EIA kit) was measured using commercially available kits (Nordic Bioscience Diagnostics, Harley, Denmark)
Determination of bone turnover biomarkers:
Serum alkaline phosphatase (ALP) was determined by ALP assay kits (DALP-250, BioAssay Systems, CA, USA) (10).
Assessment of bone mass density (BMD)
BMD was assessed by using DEXA machine was calibrated per manufacturer's instruction protocol.
Measurements were attained by positioning the rat in prone position with knee flexed and extended hips.
2-Histological study
Following decalcification in 10% EDTA, pH 7.4, the tibiae were processed histologically for paraffin embedding, and longitudinal sections were obtained and stained with H&E (11).
Morphometric studies:
Using an image analyzer (Leica version 3.7.2005 (Leica version 3.7. -2010 in histology department, Sohag university, the numbers of osteoclast and osteoblast lining the endosteum were counted under x 400 magnification in three sections from each animal.
Statistical analyses
Demographics and baseline characteristics were summarized across treatment groups using descriptive statistics. The data from both normal and osteoporotic groups were compared using the Student's t-test. Significance was set at P value of less than 0.05 for all comparisons. Data analysis were performed using the SPSS version 20 software.
Results
All statistical data are summarized in 
2-DEXA measurements:
Highly statistical significances between all the examined groups regarding the DEXA measurements (p=0.000) as summarized in table 1 and figure 1 with the lowest values in group II in comparison with the other groups.
Marked deterioration in the DEXA measurements were observed in group II when comparing between group I and group II (0.0675±0.007 vs.
0.009 ± .002, P=0.000).
There were a statistically significant improvement in the DEXA measurements in both group III 
-Serum Oxytocin level:
There were a highly statistical significance among all the examined groups regarding the OT levels (p=0.000).
There were a statistically significant decrease in the serum levels of OT in group II compared to group I (16.3±2.7 vs 29.4±3.9, P=0.313), respectively.
Also a statistically significant increase in the serum levels of OT were noticed in group IV compared to group II (28.2± 2.2 vs. 16.3± 2.7, p = 0.000) respectively.
4-Morphometric and histological results:
1-Control group:
Examination of H & E stained sections from the control group showed normal architecture of the cancellous bone; the tissue arranged as trabeculae which appear eosinophilic, numerous interconnecting bone marrow spaces of various sizes were present between the bone tissues ( Fig.   1a ). Osteocytes were seen as basophilic cells inside their lacunae in the bone lamellae.
Osteoblasts appeared with their large size, polygonal shape; with heavily basophilic cytoplasm ( Fig. 1a 2 , 1b) .The mean number of osteocytes was 40.4±4.8 cell/HPF. The mean number of osteoblasts was 20.6±1.9 cell/HPF.
2-Group II (OVX+ saline):
In group II the bone showed picture of osteoporosis in the form of; the bone lost its normal architecture, trabeculae were thin, reduced in number and sometimes fragmented and fractured. They were separated with wide marrow spaces ( Fig. 2a) . There was a marked decrease in number of osteocytes, without lacunae ( Fig.2a 2 , 2b respectively.
4-Group IV (OVX + OT 7 weeks after OVX):
H & E sections from group IV, that was treated with OT as a curative thereby showed an apparent increase in the thickness of cortical bone similar to the normal bone. No cavities were seen in the part of bone near the medullary cavity, which was occupied by red bone marrow (Fig. 5a ). Osteocytes were seen with large nucleus, also osteoblasts were ( Fig. 3a) : A photomicrograph of a section of group III at the head of the tibia showing:the bone was nearly normal, trabeculae were thickened, no fragmentation were seen. Osteoblasts (↑) were lining the trabeculae with numerous amounts. H&E (X 400) (Fig.3b) : A photomicrograph of a section of group III at the head of the tibia showing:Osteocytes (OC) were seen with large number, prominent nucleus filling the lacunae. Osteoblasts (↑) were normally distributer, lining endosteum with numerous amounts. H&E (X 400) Fig. 4a : A photomicrograph of a section of group IV at the head of the tibia showing: An apparent increase in the thickness of bone trabeculae (BT), separated by red bone marrow (BM). No cavities were seen with an improved structure, more or less similar to normal bone.
( Fig. 4b) : A photomicrograph of a section of group IV at the head of the tibia showing: Osteocytes (↑) were seen with prominent nucleus, increased in number with normally distributed matrix with no cavities appeared. H&E (X 400) The main target in treating OP is to reduce fracture risk, increase survival, and improve quality of life (4). In our study after alendronate (the drug of choice in OP treatment) was given for 7 weeks after 7 weeks of surgery in group III, there were a marked decrease in the serum ALP levels associated with increased BMD on DEXA scan.
Histologically (Fig 3 a, b ) , the results supports the alendronate action on bone in the form of increasing the bone thickness. Osteoblasts and osteocytes were noticed with numerous amounts in this group. These data confirmed the well-known role of alendronate in the treatment of OP (17, 18, and 19) .
Alendronate inhibits osteoclastic bone resorption by attaching to hydroxyapatite binding sites on bony surfaces, especially surfaces undergoing active resorption. When osteoclasts begin to resorb bone that is impregnated with alendronate, the alendronate released during resorption impairs the ability of the osteoclasts to form the ruffled border, to adhere to the bony surface, and to produce the protons necessary for continued bone resorption and 27) they found that OT can restore osteopenia by direct effect on bone cells independently on estrogen anabolic effect on bone.
Also a highly significant increase in the levels of the serum OT hormone were noticed in this group (OVX+OT) when compared with group II (p = 0.000). Histologically (Fig 4 a,b ) there were increased number of osteoblasts and osteocytes.
Moreover, bone trabeculae were thickened with no cavitation and more or less similar to normal bone.
Previous data strongly suggested that hypogonadalinduced bone loss was linked to low OT circulating levels, and that restoring OT levels could therefore reverse osteopenia (25, 26) . Other studies speculated that high circulating OT levels might mediate the anabolic skeletal recovery (27).
To the best of our knowledge this is the first study 
Conclusion:
These beneficial observations, which are discussed above, clearly showed that OT is involved in regulation of metabolic and bone balance and are opening a new window for drug development in osteoporosis therapeutics. Considering that OT is a FDA-approved drug, it would be extremely useful as skeletal anabolic agent to treat osteoporosis.
Beside this marvelous effect of OT, it is one of the happiness hormones which can improve the mood changes (e.g. Depression) associated with OP. 
